Analgesics remains the largest category in consumer health in the Nigerian market. Sales were expected to continue to rise in 2021 supported by strong brand positioning and consumer awareness.
Analgesics is seeing growth despite the increasing cost of raw materials, government policies and unstable economic conditions - which are considered to be the biggest threat to the growth of analgesics in Nigeria. Sales of analgesics like acetaminophen and ibuprofen have recorded a remarkable increase due to their widespread availability and affordability.
Local player, Emzor Pharmaceutical Industries, retains its leading position in analgesics, accounting for around a fifth of value sales, though its nearest competitor GSK Consumer Healthcare has been gaining ground over the review period. Emzor has a strong retail distribution network that is backed up by advertising at point-of-sale and online, where it has many followers on Facebook and Twitter.
The COVID-19 outbreak and the sharp decline in oil prices have severely affected Nigeria's economy. An unstable economy, government policies, and insecurity are expected to stifle growth across many product areas during the forecast period.
Acetaminophen and topical analgesics/anaesthetic are expected to have the highest value sales amongst analgesics categories during the forecast period. Acetaminophen is a popular painkiller in Nigeria, with a reputation for being remarkably safe and with few side effects.
The main analgesics distributors are focusing on standing out from competitors via a strong commitment to media advertising campaigns, particularly on radio and television. Also, as a result of the COVID-19 crisis, during which people’s movements have been restricted, a lot of advertising has moved online and there has been increased interaction on social media.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Analgesics industry in Nigeria with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Nigeria, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).See All of Our Definitions
This report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page